These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 27915196)

  • 1. Identification and characterization of a new dapoxetine impurity by NMR: Transformation of N-oxide by Cope elimination.
    Darcsi A; Rácz Á; Béni S
    J Pharm Biomed Anal; 2017 Feb; 134():187-194. PubMed ID: 27915196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure elucidation of a process-related impurity of dapoxetine.
    Darcsi A; Tóth G; Kökösi J; Béni S
    J Pharm Biomed Anal; 2014 Aug; 96():272-7. PubMed ID: 24793500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and structural elucidation of dapoxetine as an adulterant in a health supplement used for sexual performance enhancement.
    Li L; Low MY; Ge X; Bloodworth BC; Koh HL
    J Pharm Biomed Anal; 2009 Dec; 50(5):724-8. PubMed ID: 19574010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification, Characterization, and Quantification of Impurities of Safinamide Mesilate: Process-Related Impurities and Degradation Products.
    Zou L; Sun L; Zhang H; Hui W; Zou Q; Zhu Z
    J AOAC Int; 2017 Jul; 100(4):1029-1037. PubMed ID: 28150570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and characterization of degradation products of moxidectin using LC, LTQ FT-MS, H/D exchange and NMR.
    Awasthi A; Razzak M; Al-Kassas R; Greenwood DR; Harvey J; Garg S
    Anal Bioanal Chem; 2012 Nov; 404(8):2203-22. PubMed ID: 22986987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification, isolation and characterization of potential degradation products in pioglitazone hydrochloride drug substance.
    Ramulu K; Kumar TT; Krishna SR; Vasudev R; Kaviraj M; Rao BM; Rao NS
    Pharmazie; 2010 Mar; 65(3):162-8. PubMed ID: 20383934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NMR and mass spectrometric characterization of vinblastine, vincristine and some new related impurities--part II.
    Háda V; Dubrovay Z; Lakó-Futó A; Galambos J; Gulyás Z; Aranyi A; Szántay C
    J Pharm Biomed Anal; 2013 Oct; 84():309-22. PubMed ID: 23177164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification, isolation and characterization of potential degradation product in risperidone tablets.
    Bharathi Ch; Chary DK; Kumar MS; Shankar R; Handa VK; Dandala R; Naidu A
    J Pharm Biomed Anal; 2008 Jan; 46(1):165-9. PubMed ID: 17981421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural elucidation of a process-related impurity in ezetimibe by LC/MS/MS and NMR.
    Raman B; Sharma BA; Butala R; Ghugare PD; Kumar A
    J Pharm Biomed Anal; 2010 May; 52(1):73-8. PubMed ID: 20079995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a novel impurity in bulk drug eprosartan by ESI/MS(n) and NMR.
    Sun C; Wu J; Wang D; Pan Y
    J Pharm Biomed Anal; 2010 Feb; 51(3):778-83. PubMed ID: 19864105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of LC/MS, GC/MS, and LC/NMR hyphenated techniques to identify a drug degradation product in pharmaceutical development.
    Pan C; Liu F; Ji Q; Wang W; Drinkwater D; Vivilecchia R
    J Pharm Biomed Anal; 2006 Feb; 40(3):581-90. PubMed ID: 16242883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chloroquine-N-oxide, a major oxidative degradation product of chloroquine: identification, synthesis and characterization.
    Doddaga S; Peddakonda R
    J Pharm Biomed Anal; 2013; 81-82():118-25. PubMed ID: 23644906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of new impurity in didanosine.
    Srinivasa Rao DV; Srinivas N; Bharathi Ch; Prasad ChS; Dandala R; Naidu A
    J Pharm Biomed Anal; 2007 Nov; 45(3):516-20. PubMed ID: 17624711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chiral Recognition Studies of α-(Nonafluoro-tert-butoxy)carboxylic Acids by NMR Spectroscopy.
    Nemes A; Csóka T; Béni S; Farkas V; Rábai J; Szabó D
    J Org Chem; 2015 Jun; 80(12):6267-74. PubMed ID: 26024423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic interaction between udenafil and dapoxetine: a randomized, open-labeled crossover study in healthy male volunteers.
    Kim YH; Choi HY; Lee SH; Jeon HS; Lim HS; Bahng MY; Bae KS
    Drug Des Devel Ther; 2015; 9():1209-16. PubMed ID: 25759565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification, isolation and characterization of potential process-related impurity and its degradation product in vildagliptin.
    Kumar N; Devineni SR; Singh G; Kadirappa A; Dubey SK; Kumar P
    J Pharm Biomed Anal; 2016 Feb; 119():114-21. PubMed ID: 26678178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization and relative response factor determination of process related impurity in Naproxen by nuclear magnetic resonance spectroscopy.
    Iqbal MY; Rao KM; Sridhar G; Raju PP; Deshpande GR; Babu JM
    J Pharm Biomed Anal; 2011 Nov; 56(3):484-90. PubMed ID: 21782369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification, isolation and characterization of impurities of clindamycin palmitate hydrochloride.
    Bharathi Ch; Jayaram P; Sunder Raj J; Saravana Kumar M; Bhargavi V; Handa VK; Dandala R; Naidu A
    J Pharm Biomed Anal; 2008 Dec; 48(4):1211-8. PubMed ID: 18947955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel process related impurity and forced degradation study of synthetic wogonin: development of a liquid chromatographic method for purity control.
    Xia Y; Wu C; Liu W; Feng F; Li Z
    J Pharm Biomed Anal; 2012 Dec; 71():168-72. PubMed ID: 22906689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceutical impurity identification: a case study using a multidisciplinary approach.
    Alsante KM; Boutros P; Couturier MA; Friedmann RC; Harwood JW; Horan GJ; Jensen AJ; Liu Q; Lohr LL; Morris R; Raggon JW; Reid GL; Santafianos DP; Sharp TR; Tucker JL; Wilcox GE
    J Pharm Sci; 2004 Sep; 93(9):2296-309. PubMed ID: 15295790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.